chr1-179575683-G-A
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_014625.4(NPHS2):c.182C>T(p.Ala61Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000937 in 1,596,352 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A61T) has been classified as Uncertain significance.
Frequency
Consequence
NM_014625.4 missense
Scores
Clinical Significance
Conservation
Publications
- nephrotic syndrome, type 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, G2P
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00524 AC: 798AN: 152196Hom.: 6 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00115 AC: 246AN: 213816 AF XY: 0.000824 show subpopulations
GnomAD4 exome AF: 0.000483 AC: 698AN: 1444042Hom.: 6 Cov.: 31 AF XY: 0.000401 AC XY: 288AN XY: 718286 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00524 AC: 798AN: 152310Hom.: 6 Cov.: 32 AF XY: 0.00498 AC XY: 371AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:3
- -
- -
- -
not provided Benign:3
- -
- -
- -
Nephrotic syndrome, type 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at